'FDA' Category
By Simmons Hanly Conroy | May 25, 2017
Consumers Beware: How ‘Approved’ Drugs Aren’t Always Safe
According to a study in the Journal of the American Medical Association (JAMA), of the 222 drugs that were approved by the Food and Drug Administration (FDA) from 2000 to 2010, 71… Read More
By Simmons Hanly Conroy | March 24, 2015
The Ovarian Cancer Risk Factor You May Not Know
Ovarian cancer is one of the most common cancers among women. According to the American Cancer Society, an average woman’s risk of developing ovarian cancer is 1 in 75. Approximately 21,290 women… Read More
By Simmons Hanly Conroy | March 5, 2015
Testosterone Lawsuit News: FDA Orders Label Warnings on Testosterone Drugs
Testosterone therapy manufacturers must update the labels of all testosterone products to inform men about the increased risk of stroke, heart attack and death in patients taking testosterone, according to a testosterone… Read More
By Simmons Hanly Conroy | December 18, 2014
FDA Advisers Shown to Have Questionable Financial Ties
In July 2014, an adviser on a U.S. Food and Drug Administration (FDA) gynecology panel stepped down after he was questioned about conflicts of interest. It was later discovered that this panel… Read More
By Simmons Hanly Conroy | October 8, 2014
FDA Advises Drugmakers to Conduct Further Studies on Testosterone Heart Risk
An advisory panel to the U.S. Food and Drug Administration (FDA) recently voted 20-1 that further assessment of the health risks of testosterone therapy is needed among drugmakers. Among the panel, 16… Read More
By Simmons Hanly Conroy | June 10, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Simmons Hanly Conroy | May 7, 2014
FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category
The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More
By Simmons Hanly Conroy | March 7, 2014
FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs
More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More
By Simmons Hanly Conroy | February 24, 2014
Studies Point to Inconsistencies in FDA Approval Process
Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More
By Simmons Hanly Conroy | January 31, 2014
FDA Investigating Risk of Testosterone Causing Cardiovascular Events
The U.S. Food & Drug Administration is investigating the risk of testosterone treatments causing an increased rate of cardiovascular events such as heart attacks and stroke, according to a drug safety communication from the… Read More
